e8vk
Table of Contents



SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of earliest event reported: August 3, 2004


Select Medical Corporation


(Exact name of registrant as specified in charter)
         
Delaware   000-32499   23-2872718
(State of Incorporation)   (Commission File Number)   (I.R.S. Employer
Identification No.)

4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055
(Address of Principal Executive Offices) (Zip Code)

(717) 972-1100
(Registrant’s telephone number, including area code)



 


TABLE OF CONTENTS

Item 9. Regulation FD Disclosure.
SIGNATURE
Select Medical Corporation press release, dated August 3. 2004.


Table of Contents

Item 9. Regulation FD Disclosure.

     On August 3, 2004, Select Medical Corporation issued a press release. A copy of the press release is attached as Exhibit 99.1 to this report.

     The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 9 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 


Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

         
  SELECT MEDICAL CORPORATION
 
 
Date: August 3, 2004  By:   /s/ Michael E. Tarvin    
    Michael E. Tarvin   
    Senior Vice President, General Counsel and Secretary   
 

 


Table of Contents

EXHIBIT INDEX

     
Exhibit No.
  Description
99.1
  Select Medical Corporation press release, dated August 3, 2004.